1. Home
  2. NFE vs WVE Comparison

NFE vs WVE Comparison

Compare NFE & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NFE
  • WVE
  • Stock Information
  • Founded
  • NFE 2014
  • WVE 2012
  • Country
  • NFE United States
  • WVE Singapore
  • Employees
  • NFE N/A
  • WVE N/A
  • Industry
  • NFE Oil/Gas Transmission
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NFE Utilities
  • WVE Health Care
  • Exchange
  • NFE Nasdaq
  • WVE Nasdaq
  • Market Cap
  • NFE 773.2M
  • WVE 915.6M
  • IPO Year
  • NFE 2019
  • WVE 2015
  • Fundamental
  • Price
  • NFE $2.45
  • WVE $8.29
  • Analyst Decision
  • NFE Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • NFE 6
  • WVE 17
  • Target Price
  • NFE $8.92
  • WVE $19.94
  • AVG Volume (30 Days)
  • NFE 6.5M
  • WVE 2.2M
  • Earning Date
  • NFE 11-06-2025
  • WVE 07-30-2025
  • Dividend Yield
  • NFE N/A
  • WVE N/A
  • EPS Growth
  • NFE N/A
  • WVE N/A
  • EPS
  • NFE N/A
  • WVE N/A
  • Revenue
  • NFE $2,008,012,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • NFE $7.43
  • WVE N/A
  • Revenue Next Year
  • NFE $8.38
  • WVE $10.02
  • P/E Ratio
  • NFE N/A
  • WVE N/A
  • Revenue Growth
  • NFE N/A
  • WVE N/A
  • 52 Week Low
  • NFE $2.01
  • WVE $5.04
  • 52 Week High
  • NFE $16.66
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • NFE 43.46
  • WVE 41.39
  • Support Level
  • NFE $2.23
  • WVE $7.12
  • Resistance Level
  • NFE $2.76
  • WVE $10.45
  • Average True Range (ATR)
  • NFE 0.20
  • WVE 0.54
  • MACD
  • NFE 0.03
  • WVE -0.24
  • Stochastic Oscillator
  • NFE 40.91
  • WVE 33.82

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: